BioSpace News Archive

The presence of a seamless industry for managing respiratory diseases and infections has played a crucial role in driving sales across the global respiratory panel assays market.

Portable ramps, also known as portable wheelchair ramps, are gaining popularity at the back of the utility served by these ramps to several population groups.

The oxygen therapy consumables market is predicted to rise at a notable pace over the course of the forecast period from 2020 to 2030.

Pivotal trial showed more than four times as many children achieved itch reduction and more than three times as many children achieved clear or almost clear skin with Dupixent plus topical corticosteroids (TCS) compared to TCS alone

Nordic Nanovector ASA announces that the Company’s ticker symbol on the Oslo Børs will change from ‘NANO’ to ‘NANOV’ and will be effective as of the start of trading on 30 November 2020.

Syndax Pharmaceuticals, Inc. (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it will host a conference call and webcast featuring two experts in the science and treatment of chronic graft versus host disease (cG

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that the Company will host a conference call to provide a research and development (R&D) and Corporate update at 8:30 a.m. EST on December 9, 2020 . The call will include the Protagonist management team and Andrew Kuykendall , M.D., an investigator in the PTG-300

CTI BioPharma Corp. (Nasdaq: CTIC) today announced that an article highlighting pacritinib data was published in Blood Advances . The article, titled “Determining the Recommended Dose of Pacritinib: Results from the PAC203 Phase 2 Dose-Finding Study in Patients with Advanced Myelofibrosis” is available online via this link .